glp 1 intestine Understanding GLP-1 receptor agonists and their impact on drug discovery Impact of GLP-1 Receptor Agonists

The Oral Small-Molecule GLP-1 Competition Orforglipron isn't the only oral small-molecule GLP-1 agonist in development

Evidence from clinical trials remains sparse, but that is about to change

Otherwise, patients taking both a DPP4i and GLP1-RA could benefit from discontinuing the DPP4i

A small clinical study suggested that liraglutide reduced monthly migraine days by nearly half in participants with obesity

Targeted ultrasound in the same area demonstrated normal tissue planes without suspicious cystic or solid mass, further confirming the presence of normal fibroglandular tissue

Supplementary material The Supplementary Material for this article can be found online at: Abbreviations CSII, continuous subcutaneous insulin infusion